SA33 Demographic Characteristics of Patients Initiating Topical Combination Therapies for Plaque Psoriasis in Canada: A Claims-Based Analysis
This study aims to describe the demographic characteristics of Canadian patients who initiated one of the topical combination products following the notice of compliance issued by Health Canada for HP/TAZ in 2020.
Source: Value in Health - Category: International Medicine & Public Health Authors: V Gaudet, H Yang, T Bourgoin, A Sharma, M Barbeau Source Type: research
More News: Canada Health | International Medicine & Public Health | Psoriasis | Skin | Study | Taclonex